IMMU-08. PHASE I TRIAL (NCT02457845) SAFETY, TOLERABILITY AND PRELIMINARY EFFICACY OF IMMUNOVIROTHERAPY WITH HSV G207 IN CHILDREN WITH PROGRESSIVE MALIGNANT SUPRATENTORIAL BRAIN TUMORS

BACKGROUND: Outcomes for children with progressive malignant supratentorial brain tumors are dismal. Preclinical evidence indicates that pediatric brain tumors are highly sensitive to genetically engineered oncolytic HSV-1 G207, which lacks genes essential for replication in normal brain. We report...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Neuro Oncol
Main Authors: Friedman, Gregory, Bag, Asim, Madan-Swain, Avi, Li, Rong, Kachurak, Kara, Osorio, Diana, Hukin, Juliette, Martin, Allison, Pastakia, Devang, Karajannis, Matthias, Bernstock, Joshua, Fiveash, John, Reddy, Alyssa, Whitley, Richard, Gillespie, Yancey, Markert, James, Johnston, James
Formato: Artigo
Idioma:Inglês
Publicado em: Oxford University Press 2018
Assuntos:
Abstracts
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC6012830/
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/neuonc/noy059.324
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados